4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-057070
Director sold 7,500 shares at an average $136.36 ($1,022,665)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Sale : show line 1 in the form | −2,328 | $135.62 | $315,723 | 516,163 | D |
| 2020-11-02 | Sale : show line 2 in the form | −3,900 | $136.23 | $531,296 | 512,263 | D |
| 2020-11-02 | Sale : show line 3 in the form | −772 | $137.47 | $106,129 | 511,491 | D |
| 2020-11-02 | Sale : show line 4 in the form | −500 | $139.03 | $69,517 | 510,991 | D |
| Open-market sales · 7,500 sh · avg $136.36 · $1,022,665 | ||||||
Loading xslF345X03/doc4.xml…